Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease
Titel:
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease
Auteur:
Gommans, D. H. Frank Nas, Joris Pinto-Sietsma, Sara-Joan Koop, Yvonne Konst, Regina E. Mensink, Frans Aarts, Goaris W.A. Konijnenberg, Lara S.F. Cortenbach, Kimberley Verhaert, Dominique V.M. Thannhauser, Jos Mol, Jan-Quinten Rooijakkers, Maxim J.P. Vos, Jacqueline L. van Rumund, Anouke Vart, Priya Hassing, Robert-Jan Cornel, Jan-Hein de Jager, C. Peter C. van den Heuvel, Michel M. van der Hoeven, Hans G. Verbon, Annelies Pinto, Yigal M. van Royen, Niels van Kimmenade, Roland R.J. de Leeuw, Peter W. van Agtmael, Michiel A. Bresser, Paul van Gilst, Wiek H. Vonk-Noordergraaf, Anton Tijssen, Jan G.P. van Royen, Niels de Jager, C. Peter C. van den Heuvel, Michel M. van der Hoeven, Hans G. Verbon, Annelies Pinto, Yigal M. van Kimmenade, Roland R.J.